[Microvascular thrombosis and clinical implications]

Area of Science:

• * Medicine
• * Pathology
• * Immunology

Background:

• * Microvascular thrombosis is a common feature in critical human diseases, including disseminated intravascular coagulation, thrombotic microangiopathy, and sickle cell disease.
• * Recent findings indicate microvascular thrombosis plays a role in COVID-19 pathogenesis, contributing to organ damage in the lungs and other organs.
• * The interplay between inflammation and microvascular thrombosis, termed thromboinflammation or immunothrombosis, is increasingly recognized in various pathologies.

Purpose of the Study:

• * To explore the intricate relationship between inflammation and thrombosis within the microcirculation.
• * To highlight the significance of understanding thromboinflammation for developing novel therapeutic strategies.

Main Methods:

• * Literature review and synthesis of existing research on microvascular thrombosis and inflammation.
• * Analysis of pathological mechanisms linking inflammation to clot formation in small vessels.
• * Examination of clinical data from diseases characterized by microvascular thrombosis and inflammation.

Main Results:

• * Microvascular thrombosis is a shared pathophysiological mechanism across diverse diseases.
• * Thromboinflammation is a critical factor in the progression of organ injury, notably in COVID-19.
• * The association between inflammation and thrombosis in the microcirculation is a crucial area for medical research.

Conclusions:

• * A deeper comprehension of the links between inflammation and microvascular thrombosis is essential.
• * Targeting thromboinflammation pathways may offer new therapeutic avenues for diseases involving microvascular clotting and organ damage.